Effector T cell apoptosis induction

Effector T cell apoptosis induction refers to the process of triggering programmed cell death specifically in activated or antigen-primed effector T cells. This is an important regulatory mechanism within the immune system that helps maintain homeostasis by eliminating excess or potentially harmful activated T cells after an immune response. The process can be initiated through both intrinsic pathways—such as those triggered by DNA damage or metabolic stress—and extrinsic pathways—mediated by death ligands like Fas ligand (FasL), tumor necrosis factor-alpha (TNFα), and TNF-related apoptosis-inducing ligand (TRAIL). These ligands bind their respective receptors on effector T cells, leading to activation of caspases and execution of apoptotic programs[1][2]. Effector T cell apoptosis is crucial for controlling inflammation and preventing autoimmunity. In therapeutic contexts such as cancer immunotherapy or treatment with glucocorticoids, modulation of this process can influence disease outcomes[1][2]. However, it is not a single molecule or receptor but rather a biological function involving multiple molecular players.

Other names

Induction of effector T cell apoptosisEffector T lymphocyte apoptosis induction